Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton(University Hospitals Birmingham NHS Foundation Trust), John P. Neoptolemos(University of Liverpool), Tom Roques(Norfolk and Norwich University Hospital), Stephen Falk(At Bristol), Jonathan Wadsley(Weston Park Cancer Centre), Srinivasan Madhusudan(University of Nottingham), Angus Robinson(Royal Sussex County Hospital), Charlotte Rawcliffe(University of Liverpool), Karen McAdam(Peterborough City Hospital), Tamas Hickish(Southampton General Hospital), William Greenhalf(University of Liverpool), Angel Garcia-Alonso(Glan Clwyd Hospital), Nick Wadd(South Tees Hospitals NHS Foundation Trust), JEFF EVANS(University of Glasgow), David Propper(St Bartholomew's Hospital), Dean J. Naisbitt(University of Liverpool), Timothy Iveson(University Hospital Southampton NHS Foundation Trust), David Cunningham(Royal Marsden NHS Foundation Trust), Victoria Shaw(University of Liverpool), Pippa Corrie(University of Cambridge), Caroline Archer(Queen Alexandra Hospital), Juan W. Valle(Cancer Research UK Manchester Institute), Alan Anthoney(St James's University Hospital), Gemma Nanson(Cancer Research UK), Trevor F. Cox(University of Liverpool), Paul J. Ross(King's College Hospital NHS Foundation Trust), William P. Steward(University of Leicester), Paul Silcocks(University of Liverpool), Mark Harrison(Hillingdon Hospitals NHS Foundation Trust), Martin Eatock(Queen's University Belfast), Fareeda Y. Coxon(Newcastle upon Tyne Hospitals NHS Foundation Trust), M. Nicolson, Eithne Costello(University of Liverpool)
Cited by 374
Related Papers
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
|New England Journal of Medicine|2008|2.3k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k